Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Relypsa Inc (NASDAQ:RLYP)

31.97
Delayed Data
As of Aug 26
 +0.01 / +0.03%
Today’s Change
10.26
Today|||52-Week Range
32.12
+12.81%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Other
MARKET CAP
$1.4B

Company Description

Relypsa, Inc. operates as a bio-pharmaceutical company, which is focused on the development and commercialization of polymeric drugs to treat disorders in the areas of renal, cardiovascular and metabolic diseases. The company was founded on October 29, 2007 and is headquartered in Redwood City, CA.

Contact Information

Relypsa, Inc.
100 Cardinal Way
Redwood City California 94063
P:(650) 421-9500
Investor Relations:

Employees

Shareholders

Mutual fund holders37.87%
Other institutional29.59%
Individual stakeholders29.35%

Top Executives

John A. OrwinPresident, Chief Executive Officer & Director
Kristine McClintock BallChief Financial Officer & Senior Vice President
Wilhelm StahlChief Technology Officer & Senior Vice President
Lance BermanChief Medical Officer & Senior Vice President
Stephen D. HarrisonChief Scientific Officer & Senior Vice President